- Home
- TECH vs MKTX Comparison
TECH vs MKTX Comparison
Compare TECH & MKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TECH
- MKTX
- Stock Information
- Founded
- TECH 1976
- MKTX 2000
- Country
- TECH United States
- MKTX United States
- Employees
- TECH N/A
- MKTX N/A
- Industry
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- MKTX Investment Bankers/Brokers/Service
- Sector
- TECH Health Care
- MKTX Finance
- Exchange
- TECH Nasdaq
- MKTX Nasdaq
- Market Cap
- TECH 7.9B
- MKTX 8.1B
- IPO Year
- TECH 1989
- MKTX 2004
- Fundamental
- Price
- TECH $48.07
- MKTX $213.25
- Analyst Decision
- TECH Buy
- MKTX Buy
- Analyst Count
- TECH 10
- MKTX 9
- Target Price
- TECH $73.44
- MKTX $241.78
- AVG Volume (30 Days)
- TECH 2.3M
- MKTX 521.7K
- Earning Date
- TECH 05-07-2025
- MKTX 05-07-2025
- Dividend Yield
- TECH 0.67%
- MKTX 1.44%
- EPS Growth
- TECH N/A
- MKTX N/A
- EPS
- TECH 0.83
- MKTX 5.76
- Revenue
- TECH $1,208,770,000.00
- MKTX $815,355,000.00
- Revenue This Year
- TECH $8.19
- MKTX $7.50
- Revenue Next Year
- TECH $8.61
- MKTX $10.21
- P/E Ratio
- TECH $57.61
- MKTX $36.57
- Revenue Growth
- TECH 4.72
- MKTX 7.33
- 52 Week Low
- TECH $46.44
- MKTX $186.84
- 52 Week High
- TECH $85.57
- MKTX $296.68
- Technical
- Relative Strength Index (RSI)
- TECH 39.46
- MKTX 42.82
- Support Level
- TECH $46.77
- MKTX $209.80
- Resistance Level
- TECH $54.40
- MKTX $232.84
- Average True Range (ATR)
- TECH 2.15
- MKTX 6.25
- MACD
- TECH 0.23
- MKTX -1.87
- Stochastic Oscillator
- TECH 8.82
- MKTX 16.06
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
About MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.